Claris Law Legal Blogging Community

Name:

E-mail:

Phone Number:

Zip Code:

Your Question:

Editor: Robert Binstock
Profession: Paxil Side Effect Attorney

Category: Paxil News

A new bill has passed in both houses of Congress that will revamp the FDA. The bill is expected to be signed into law by the President in the very near future. The bill consists of many renovations that are really necessary for the FDA to ensure a safer drug market in the future. In the wake of the Vioxx recall and all of the controversy surrounding drugs like Paxil and Avandia it is defiantly time for FDA reform.

Advocates for higher standards of drug approval are viewing the bill's passage as a victory, and insist that it will better aid the FDA in monitoring side effects and allow for a more prompt response when problems do arise. The bill will allow the FDA to more easily dictate the claims that companies place on items without the overbearing influence from the negotiating parties for big pharmaceutical companies.

FDA funding will be increased and they will be granted new authority to enforce post approval cinincal studies and the power to fine companies for noncompliance. Companies will also pay higher fees when submitting new drug applications resulting in 25 percent increase in industry funding.

The biggest and best renovation will be the introduction of a registry that will require drug companies to list all clinical trials and post the results of completed trials. The database will be regulate by the National Institutes of Health and will be accessible by the public through a web-based program.

Hopefully the new bill will soon become a law and the American public will soon be reaping the benefits of a stricter and hopefully safer Food and Drug Administration.